Skip to main content
Premium Trial:

Request an Annual Quote

Deutsche Securities Downgrades PerkinElmer on Q2 Profit Decline

NEW YORK (GenomeWeb News) — Deutsche Securities today downgraded shares of PerkinElmer to a “Hold” from a “Buy” after the company reported a 15-percent reduction in profit in the second quarter.
 
As GenomeWeb News reported today, PerkinElmer said net income declined to $24 million from $29 million last year.
The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.